Rapid analysis of gene expression changes caused by liver carcinogens and chemopreventive agents using a newly developed three-dimensional microarray system

Cancer Science

Volumn 95, Issue 2, 2004, Pages 123-130

  Hokaiwado, Naomi ^a   Asamoto, Makoto ^a   Tsujimura, Kazunari ^a   Hirota, Takeshi ^b   Ichihara, Toshio ^b   Satoh, Takatomo ^c   Shirai, Tomoyuki ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Daiyukai Research Institute for Medical Science   (Japan)

^c OLYMPUS CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3,8 DIMETHYLIMIDAZO[4,5 F]QUINOXALINE; ACETIC ACID DERIVATIVE; AURAPTENE; CAFFEIC ACID; CARCINOGEN; CATECHOL; CLOFIBRATE; DIETHYLNITROSAMINE; NOBILETIN; PHENOBARBITAL; RNA;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARCINOMA CELL; CHEMICAL ANALYSIS; CHEMOPROPHYLAXIS; CLASSIFICATION; CONTROLLED STUDY; DEVICE; DNA HYBRIDIZATION; DNA MICROARRAY; DOWN REGULATION; GENE CLUSTER; GENE EXPRESSION; GENOTOXICITY; LIVER CARCINOGENESIS; LIVER WEIGHT; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; UNINDEXED SEQUENCE; UPREGULATION;

ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; GENE EXPRESSION REGULATION, NEOPLASTIC; IN SITU HYBRIDIZATION; LIVER NEOPLASMS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 1642527133     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2004.tb03192.x     Document Type: Article

References (37)

1. Aardema MJ, MacGregor JT. Toxicology and genetic toxicology in the new era of "tOxicogenomics": impact of "-omics" technologies. Mutat Res 2002; 499: 13-25.
2. Boorman GA, Anderson SP, Casey WM, Brown RH, Crosby LM, Gottschalk K, Easton M, Ni H, Morgan KT. Toxicogenomics, drug discovery, and the pathologist. Toxicol Pathol 2002; 30: 15-27.
3. Boorman GA, Haseman JK, Waters MD, Hardisty JF, Sills RC. Quality review procedures necessary for rodent pathology databases and toxicogenomic studies: The National Toxicology Program experience. Toxicol Pathol 2002; 30: 88-92.
4. Burchiel SW, Knall CM, Davis JW 2nd, Paules RS, Boggs SE, Afshari CA. Analysis of genetic and epigenetic mechanisms of toxicity: potential roles of toxicogenomics and proteomics in toxicology. Toxicol Sci 2001; 59: 193-5.
5. Hamadeh HK, Bushel PR, Jayadev S, Martin K, DiSorbo O, Sieber S, Bennett L, Tennant R, Stoll R, Barrett JC, Blanchard K, Paules RS, Afshari CA. Gene expression analysis reveals chemical-specific profiles. Toxicol Sci 2002; 67: 219-31.
6. Morgan KT. Gene expression analysis reveals chemical-specific profiles. Toxicol Sci 2002; 67: 155-6.
7. Nuwaysir EF, Bittner M, Trent J, Barrett JC, Afshari CA. Microarrays and toxicology: The advent of toxicogenomics. Mol Carcinog 1999; 24: 153-9.
8. Pennie WD, Woodyatt NJ, Aldridge TC, Orphanides G. Application of genomics to the definition of the molecular basis for toxicity. Toxicol Lett 2001; 120: 353-8.
9. Reynolds LJ, Richards RJ. Can toxicogenomics provide information on the bioreactivity of diesel exhaust particles? Toxicology 2001; 165: 145-52.
10. Simmons PT, Portier CJ. Toxicogenomics: The new frontier in risk analysis. Carcinogenesis 2002; 23: 903-5.
11. van Beuningen R, van Damme H, Boender P, Bastiaensen N, Chan A, Kievits T. Fast and specific hybridization using flow-through microarrays on porous metal oxide. Clin Chem 2001; 47: 1931-3.
12. Cheek BJ, Steel AB, Torres MP, Yu YY, Yang H. Chemiluminescence detection for hybridization assays on the flow-thru chip, a three-dimensional microchannel biochip. Anal Chem 2001; 73: 5777-83.
13. Benoit V, Steel A, Torres M, Yu YY, Yang H, Cooper J. Evaluation of three-dimensional microchannel glass biochips for multiplexed nucleic acid fluorescence hybridization assays. Anal Chem 2001; 73: 2412-20.
14. Maekawa M, Taniguchi T, Tatebayashi C, Horii T, Takeshita A, Sugimura H, Sugano K, Yonekawa H, Nagaoka T, Kanno T. Basic studies on mutation analysis of K-ras codon 12 by use of three-dimensional microarray system. Clin Pathol 2003; 51: In press (in Japanese).
15. Watanabe K, Williams GM. Enhancement of rat hepatocellular-altered foci by the liver tumor promoter phenobarbital: evidence that foci are precursors of neoplasms and that the promoter acts on carcinogen-induced lesions. J Natl Cancer Inst 1978; 61: 1311-4.
16. Rice JM, Diwan BA, Hu H, Ward JM, Nims RW, Lubet RA. Enhancement of hepatocarcinogenesis and induction of specific cytochrome P450-dependent monooxygenase activities by the barbiturates allobarbital, aprobarbital, pentobarbital, secobarbital and 5-phenyl- and 5-ethylbarbituric acids. Carcinogenesis 1994; 15: 395-402.
17. Tsuda H, Asamoto M, Baba-Toriyama H, Iwahori Y, Hori T, Kim DJ, Tsuchiya T, Mutai M, Yamasaki H. Clofibrate-induced neoplastic development in the rat liver is associated with decreased connexin 32 expression but not with a co-ordinated shift in expression of marker enzymes. Toxicol Lett 1995; 82-83: 693-9.
18. Tsuda H, Asamoto M, Iwahori Y, Hori T, Ota T, Baba-Toriyama H, Uehara N, Kim DJ, Krutovskikh VA, Takasuka N, Tsuchiya T, Mutai M, Tatematsu M, Yamasaki H. Decreased connexin32 and a characteristic enzyme phenotype in clofibrate-induced preneoplastic lesions not shared with spontaneously occurring lesions in the rat liver. Carcinogenesis 1996; 17: 2441-8.
19. Barbason H, Betz EH. Proliferation of preneoplastic lesions after discontinuation of chronic DEN feeding in the development of hepatomas in rat. Br J Cancer 1981; 44: 561-6.
20. Turesky RJ, Markovic J, Bracco-Hammer I, Fay LB. The effect of dose and cytochrome P450 induction on the metabolism and disposition of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline (MeIQx) in the rat. Carcinogenesis 1991; 12: 1847-55.
21. Tanaka T, Kawabata K, Kakumoto M, Hara A, Murakami A, Kuki W, Takahashi Y, Yonei H, Maeda M, Ota T, Odashima S, Yamane T, Koshimizu K, Ohigashi H. Citrus auraptene exerts dose-dependent chemopreventive activity in rat large bowel tumorigenesis: The inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drug-metabolizing enzymes. Cancer Res 1998; 58: 2550-6.
22. Tanaka T, Kawabata K, Kakumoto M, Makita H, Hara A, Mori H, Satoh K, Murakami A, Kuki W, Takahashi Y, Yonei H, Koshimizu K, Ohigashi H. Citrus auraptene inhibits chemically induced colonic aberrant crypt foci in male F344 rats. Carcinogenesis 1997; 18: 2155-61.
23. Tanaka T, Kawabata K, Kakumoto M, Makita H, Matsunaga K, Mori H, Satoh K, Hara A, Murakami A, Koshimizu K, Ohigashi H. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1′-acetoxychavicol acetate. Jpn J Cancer Res 1997; 88: 821-30.
24. Tanaka T, Kohno H, Shimada R, Kagami S, Yamaguchi F, Kataoka S, Ariga T, Murakami A, Koshimizu K, Ohigashi H. Prevention of colonic aberrant crypt foci by dietary feeding of garcinol in male F344 rats. Carcinogenesis 2000; 21: 1183-9.
25. Kohno H, Yoshitani S, Tsukio Y, Murakami A, Koshimizu K, Yano M, Tokuda H, Nishino H, Ohigashi H, Tanaka T. Dietary administration of citrus nobiletin inhibits azoxymethane-induced colonic aberrant crypt foci in rats. Life Sci 2001; 69: 901-13.
26. Tanaka T, Shimizu M, Kohno H, Yoshitani S, Tsukio Y, Murakami A, Safitri R, Takahashi D, Yamamoto K, Koshimizu K, Ohigashi H, Mori H. Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet. Life Sci 2001; 69: 1935-45.
27. Ito N, Tsuda H, Tatematsu M, Inoue T, Tagawa Y, Aoki T, Uwagawa S, Kagawa M, Ogiso T, Masui T, et al. Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats-an approach for a new medium-term bioassay system. Carcinogenesis 1988; 9: 387-94.
28. Kitano M, Wanibuchi H, Kikuzaki H, Nakatani N, Imaoka S, Funae Y, Hayashi S, Fukushima S. Chemopreventive effects of coumaperine from pepper on the initiation stage of chemical hepatocarcinogenesis in the rat. Jpn J Cancer Res 2000; 91: 674-80.
29. Zhong H, Simons J. Direct comparison of GAPDH, beta-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia. Biochem Biophys Res Commun 1999; 259: 523-6.
30. Steele B, Meyers C, Ozbun M. Variable expression of some "hOusekGeping" genes during human keratinocyte differentiation. Anal Biochem 2002; 307: 341-7.
31. Gong Y, Cui L, Minuk G. Comparison of glyceraldehyde-3-phosphate dehydrogenase and 28s-ribosomal RNA gene expression in human hepatocellular carcinoma. Hepatology 1996; 23: 734-7.
32. Hirose M, Takesada Y, Tanaka H, Tamano S, Kato T, Shirai T. Carcinogenicity of antioxidants BHA, caffeic acid, sesamol, 4-methoxyphenol and catechol at low doses, either alone or in combination, and modulation of their effects in a rat medium-term multi-organ carcinogenesis model. Carcinogenesis 1998; 19: 207-12.
33. Hagiwara A, Tanaka H, Imaida K, Tamano S, Fukushima S, Ito N. Correlation between medium-term multi-organ carcinogenesis bioassay data and long-term observation results in rats. Jpn J Cancer Res 1993; 84: 237-45.
34. Hagiwara A, Kokubo Y, Takesada Y, Tanaka H, Tamano S, Hirose M, Shirai T, Ito N. Inhibitory effects of phenolic compounds on development of naturally occurring preneoplastic hepatocytic foci in long-term feeding studies using male F344 rats. Teratog Carcinog Mutagen 1996; 16: 317-25.
35. Yamaguchi F, Ariga T, Yoshimura Y, Nakazawa H. Antioxidative and anti-glycation activity of garcinol from Garcinia indica fruit rind. J Agric Food Chem 2000; 48: 180-5.
36. Murakami A, Takahashi D, Kinoshita T, Koshimizu K, Kim HW, Yoshihiro A, Nakamura Y, Jiwajinda S, Terao J, Ohigashi H. Zerumbone, a Southeast Asian ginger sesquiterpene, markedly suppresses free radical generation, proinflammatory protein production, and cancer cell proliferation accompanied by apoptosis: The alpha, beta-unsaturated carbonyl group is a prerequisite. Carcinogenesis 2002; 23: 795-802.
37. Ito N, Tamano S, Shirai T. A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals. Cancer Sci 2003; 94: 3-8.